Real-World Effectiveness of Ustekinumab in Ulcerative Colitis in a United States Multicenter Cohort Consortium.

Andres J Yarur Ryan C UngaroKatherine HuangWenfei WangPriya SasankanMir ZulqarnainAmanda M JohnsonGeoffrey BaderCarl KayNicholas CostableDavid DulaneyMarc FensterPoonam Beniwal-PatelGaurav SyalAnish PatelEdward LoftusJoel PekowBenjamin CohenParakkal Deepak

Published in: Inflammatory bowel diseases (2024)

In a population enriched with refractory UC, ustekinumab was well tolerated and induced remission in a significant number of patients. Larger studies with a longer follow-up are warranted.

Keyphrases

ulcerative colitis
end stage renal disease
ejection fraction
newly diagnosed
randomized controlled trial
systematic review
prognostic factors
high glucose
diabetic rats
rheumatoid arthritis
oxidative stress
endothelial cells
clinical trial
cross sectional
disease activity